Transformational cell therapies for patients with pancreatic disease

Peter James

Peter James

Non-Executive Director

Mr. James has over 30 years’ experience in industries with emerging technologies, and has extensive experience as Chair, Non-Executive Director and Chief Executive Officer across a range of publicly listed and private companies. He is currently Chair of ASX-listed companies Macquarie Telecom Ltd, nearmap Ltd, Dreamscape Networks Ltd, DroneShield Limited and UUV Aquabotix Limited.

Mr. James has recently completed 12 years as a Non-Executive Director for ASX-listed iiNet, Australia’s second largest DSL Internet Services Provider, chairing iiNet’s Strategy and Innovation Committee. iiNet was recently acquired by TPG Telecom for $1,560,000,000. He travels extensively reviewing innovation and consumer trends primarily in the US and also Asia and he is a successful investor in a number of digital media, e-commerce and technology businesses in Australia and the US.

Mr. James is an experienced business leader with significant strategic and operational expertise. He is a Fellow of the Australian Institute of Company Directors, a Member of the Australian Computer Society and holds a BA Degree with Majors in Computer Science and Business. Mr. James does not expect that his other directorships will impact his ability to act as a Director of the Company.

Kyslecel personalized cell therapy for chronic pancreatitis. Because pain should not define your life.